4 transcripts
PRCT
Earnings call transcript
NASDAQ
2024 Q2
1 Aug 24
will continue to leverage our commercial and clinical investments to execute on our long-term strategy. Have a great day, and I look forward to seeing
PRCT
Earnings call transcript
NASDAQ
2024 Q1
1 May 24
is the aforementioned ASC and is included in our U.S. installed base of 354.
Our primary commercial strategy remains focused on penetrating BPH hospitals and partnering
PRCT
Earnings call transcript
NASDAQ
2023 Q4
27 Feb 24
of 2,700 total hospitals that perform BPH surgeries. While our initial commercial strategy was to target the most influential KOLs at the 860 high
PRCT
Earnings call transcript
NASDAQ
2023 Q2
27 Jul 23
from Japan in 2023, we view Japan as a very attractive market long term. Like the U.S. and United Kingdom, our strategy is to lead with clinical data
- Prev
- 1
- Next